Rosenberg MA, Maziarz M, Tan AY, Glazer NL, Zieman SJ, Kizer JR, Ix JH, Djoussé L, Siscovick DS, Heckbert SR, et al. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS). Am Heart J. 2014  ;167(5):723-8.e2.

Agarwal I, Glazer NL, Barasch E, Biggs ML, Djoussé L, Fitzpatrick AL, Gottdiener JS, Ix JH, Kizer JR, Rimm EB, et al. Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study. Circ Arrhythm Electrophysiol. 2014  ;7(4):583-9.

Agarwal I, Glazer NL, Barasch E, Biggs ML, Djoussé L, Fitzpatrick AL, Gottdiener JS, Ix JH, Kizer JR, Rimm EB, et al. Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study. Am J Epidemiol. 2014  ;179(11):1331-9.

Agarwal I, Glazer NL, Barasch E, Djoussé L, Gottdiener JS, Ix JH, Kizer JR, Rimm EB, Siscovick DS, King GL, et al. Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study. Metabolism. 2015  ;64(10):1316-23.

Agarwal I, Arnold A, Glazer NL, Barasch E, Djoussé L, Fitzpatrick AL, Gottdiener JS, Ix JH, Jensen RA, Kizer JR, et al. Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study. Atherosclerosis. 2015  ;239(2):539-46.

Ix JH, Biggs ML, Mukamal K, Djoussé L, Siscovick D, Tracy R, Katz R, Delaney JA, Chaves P, Rifkin DE, et al. Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study. J Am Soc Nephrol. 2015  ;26(10):2494-503.